This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Advanced Devices For Injectable Drugs: Products, Players And Prospects - 2013 Report

DUBLIN, Ireland, March 25, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the " Advanced Devices for Injectable Drugs. Products, Players and Prospects" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines injection devices engineered with features that advance the state-of-the-art for injectable drugs, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injection devices on the competitive landscape

- Analyzes advanced syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

- Provides detailed descriptions advanced devices for injectable drugs and assesses the impact of advanced features on therapeutic segments

- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered:

1. Executive Summary

2. Injectable Drug Market Dynamics

3. The Injectable Drug Ecosystem

- Therapeutic Demand Drivers

- Specialty Injection Device Demand Drivers

- Chronic Conditions and Self-Administration

- The Growth of Biologicals

- Shifting Patient Demographics

- Drug Economics, Safety and Compliance

- Device Design and Innovation

- Competitive Landscape

- Technology Market Drivers

4. Advanced Autoinjectors

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs